首页> 外文期刊>Medicine. >Effect of naloxone on intravenous fentanyl patient-controlled analgesia after laparoscopic cholecystectomy
【24h】

Effect of naloxone on intravenous fentanyl patient-controlled analgesia after laparoscopic cholecystectomy

机译:纳洛酮对腹腔镜胆囊切除术后静脉芬太尼患者自控镇痛的影响

获取原文
获取外文期刊封面目录资料

摘要

This study aims to evaluate the effect of naloxone on intravenous fentanyl patient-controlled analgesia after laparoscopic cholecystectomy under total intravenous anesthesia. A total of 90 patients, who underwent intravenous fentanyl patient-controlled analgesia after laparoscopic cholecystectomy under total intravenous anesthesia, were included into this study. All patients were randomly divided into 3 groups (each group, n=30): naloxone group (naloxone+fentanyl), tropisetron group (tropisetron+fentanyl), and fentanyl group (fentanyl). Patients in each group were given a corresponding dose of naloxone. Postoperative analgesia effect and the incidence of side effects such as nausea and vomiting were observed. Small doses of naloxone or tropisetron combined with fentanyl used for intravenous patient-controlled analgesia can significantly reduce the incidence of nausea and vomiting. Six hours after surgery, visual analogue scale (VAS) scores were significantly lower in patients that underwent intravenous patient-controlled analgesia using low-dose naloxone combined with fentanyl compared with patients who received fentanyl alone; however, the postoperative analgesic effect of tropisetron was not observed. Compared with the combination of tropisetron and fentanyl, low-dose naloxone combined with fentanyl can obviously reduce the incidence of nausea and vomiting in patients who underwent intravenous patient-controlled analgesia after laparoscopic cholecystectomy, and enhance the analgesic effect of fentanyl 6 hours after surgery. Low-dose naloxone can reduce the incidence of nausea and vomiting in patients who underwent laparoscopic cholecystectomy under total intravenous anesthesia, and exhibits a certain synergic analgesic effect.
机译:这项研究旨在评估在全麻下腹腔镜胆囊切除术后纳洛酮对静脉芬太尼患者自控镇痛的作用。本研究共纳入90例患者,他们在完全静脉麻醉下进行了腹腔镜胆囊切除术后接受芬太尼患者控制的静脉镇痛。将所有患者随机分为3组(每组30例):纳洛酮组(纳洛酮+芬太尼),托吡司酮组(tropisetron +芬太尼)和芬太尼组(芬太尼)。每组患者均给予相应剂量的纳洛酮。观察到术后镇痛作用以及恶心和呕吐等副作用的发生率。小剂量的纳洛酮或tropisetron联合芬太尼用于静脉内患者自控镇痛可以显着降低恶心和呕吐的发生率。术后六个小时,与单独接受芬太尼的患者相比,使用低剂量纳洛酮联合芬太尼进行静脉内患者自控镇痛的患者的视觉模拟量表(VAS)评分明显降低;然而,未观察到托吡司琼的术后镇痛作用。与托吡司酮和芬太尼的组合相比,低剂量纳洛酮联合芬太尼可以明显降低腹腔镜胆囊切除术后接受静脉自控镇痛的患者的恶心和呕吐的发生率,并在术后6小时提高芬太尼的镇痛效果。小剂量纳洛酮可以降低全静脉麻醉下腹腔镜胆囊切除术患者的恶心和呕吐发生率,并表现出一定的协同镇痛作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号